NCT05047822View on ClinicalTrials.gov

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

CompletedOBSERVATIONAL
Enrollment

18,373,714

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

January 27, 2023

Study Completion Date

January 27, 2023

Conditions
Covid-19 Infection
Trial Locations (1)

Unknown

Research Site, Leeds

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

The Chancellor, Masters and Scholars of the University of Oxford

UNKNOWN

lead

AstraZeneca

INDUSTRY